logo
Plus   Neg
Share
Email

Bristol-Myers Says FDA Expands Approval Of Sprycel

Bristol-Myers Squibb Co. (BMY) announced the U.S. Food and Drug Administration (FDA) has expanded the indication for Sprycel or dasatinib tablets to include the treatment of children with Philadelphia chromosome-positive or Ph+ chronic myeloid leukemia or CML in chronic phase or CP.

The approval for Sprycel in pediatric patients with Ph+ CML in chronic phase was granted under priority review, and the indication received orphan drug designation from the FDA.

The safety and efficacy of Sprycel in pediatric patients was evaluated in two pediatric studies of 97 patients with CP-CML: an open-label, non-randomized, dose-ranging trial (NCT00306202) and an open-label, non-randomized, single-arm trial (NCT00777036).

Among the 97 patients in the two studies, 51 patients (exclusively from the single-arm trial) had newly diagnosed CP-CML, and 46 patients (17 from the dose-ranging trial and 29 from the single-arm trial) were resistant or intolerant to previous treatment with imatinib.

As part of its commitment to children and adolescents with cancer, Bristol-Myers Squibb continues to explore pediatric applications for investigational oncology agents within its broad development program. In addition, Bristol-Myers Squibb supports organizations and initiatives focused on pediatric patients and their families.

For comments and feedback contact: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Malaysia has filed criminal charges against Goldman Sachs and two of the bank's former employees in connection with a corruption and money laundering probe tied to that country's sovereign wealth fund, 1 Malaysia Development Bhd, or 1MDB. Shares of Goldman Sachs are losing more than 2 percent in regular trading on the New York Stock Exchange. Alphabet Inc.'s Google said Monday that it will expand its presence in New York City by investing over $1 billion in capital requirements to establish a new campus known as Google Hudson Square. Google noted that its investment in New York is a huge part of its commitment to grow and invest in U.S. facilities, offices and jobs. Blockchain and artificial intelligence are the fastest-growing job categories, according to a report published by LinkedIn, the networking platform for professionals. Blockchain Developer is topping the list amid the ongoing hype around blockchain and cryptocurrency. As per the Emerging Jobs Report for 2018, the U.S has seen a surge in demand for people with blockchain development skills.
Follow RTT